A Biorepository of Multiple Allergic Diseases (MADREP)
This study, called MADREP, is creating a collection of information and samples from people with various allergic or sinus conditions, like asthma, eczema, and hay fever. Researchers want to gather clinical details, lab results, and samples such as blood, urine, and skin swabs to better understand these diseases. The goal is to build a resource that will help scientists learn more about how to prevent and treat allergic conditions. You can join if you are between 3 and 100 years old and have a suspected or confirmed allergic, atopic (a tendency to develop allergies), respiratory, or nasal/sinus disorder. This study is currently ongoing, but the specific recruitment status is unclear.
- Study design
- This is an observational study aiming to enroll 10,000 participants. It is a single-site repository study.
- What's involved
- You will have at least one clinic visit, and most participants will have a baseline visit, an annual visit, and an end-of-study visit. The study duration for participants is 1 to 3 years.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is to create a repository of data and specimens, measured at 20 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Paneez Khoury, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Create a repository of clinical, laboratory, and diagnostic data and specimens from a cohort of suspected or confirmed atopic or allergic individuals with diverse disorders seen by allergist-immunologists and rhinologists.20 years